ES2090273T3 - Estuche para el dosificado especifico de la angiotensina ii. - Google Patents

Estuche para el dosificado especifico de la angiotensina ii.

Info

Publication number
ES2090273T3
ES2090273T3 ES91401876T ES91401876T ES2090273T3 ES 2090273 T3 ES2090273 T3 ES 2090273T3 ES 91401876 T ES91401876 T ES 91401876T ES 91401876 T ES91401876 T ES 91401876T ES 2090273 T3 ES2090273 T3 ES 2090273T3
Authority
ES
Spain
Prior art keywords
ang
antibody
solution
angiotensin
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91401876T
Other languages
English (en)
Inventor
Dominique Simon
Jean Marchand
Gabriel Badouaille
Bernard Romestand
Jean-Alain Fehrentz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2090273T3 publication Critical patent/ES2090273T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN ESTUCHE PARA LA DOSIFICACION DE LA ANGIOTENSINA II QUE COMPRENDE: EL ANTICUERPO ANTI-ANG II, UNA SOLUCION DE ANG II MARCADA, SOLUCIONES QUE CONTIENEN LOS ETALONES DE ANG II EN CONCENTRACIONES CONOCIDAS Y CRECIENTES, LA O LAS SOLUCIONES DE LAVADO NECESARIAS, UNA SOLUCION DE ANTICUERPO ANTI-ANG III, PRESENTANDO DICHO ANTICUERPO UNA REACCION CRUZADA CON LA ANG II, INFERIOR A 10% PREFERENTEMENTE A 5%, Y, EVENTUALMENTE, UNA SOLUCION DE ANTICUERPOS ANTI-ANG I Y/O UNA SOLUCION DE ANTICUERPO ANTIPEPTIDO Y/O UNA SOLUCION DE ANTICUERPO ANTIHEXAPEPTIDO , PRESENTANDO DICHOS ANTICUERPOS UNA REACCION CRUZADA CON LA ANG II INFERIOR A 10%, PREFERENTEMENTE INFERIOR A 5%. LOS DERIVADOS PEPTIDICOS Y LOS ANTICUERPOS ESPECIFICOS CONTRA ESTOS DERIVADOS PARA UTILIZACION EN EL ESTUCHE Y UN METODO DE DOSIFICACION DE ANGIOTENSINA II QUE UTILIZA ESTE ESTUCHE TAMBIEN SON DESCRITOS.
ES91401876T 1990-07-05 1991-07-05 Estuche para el dosificado especifico de la angiotensina ii. Expired - Lifetime ES2090273T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008563A FR2664386B1 (fr) 1990-07-05 1990-07-05 Trousse pour le dosage specifique de l'angiotensine ii.

Publications (1)

Publication Number Publication Date
ES2090273T3 true ES2090273T3 (es) 1996-10-16

Family

ID=9398408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91401876T Expired - Lifetime ES2090273T3 (es) 1990-07-05 1991-07-05 Estuche para el dosificado especifico de la angiotensina ii.

Country Status (18)

Country Link
US (1) US5296354A (es)
EP (1) EP0466565B1 (es)
JP (1) JPH04232462A (es)
KR (1) KR920003057A (es)
AT (1) ATE138386T1 (es)
AU (1) AU650028B2 (es)
CA (1) CA2046188C (es)
DE (1) DE69119656T2 (es)
DK (1) DK0466565T3 (es)
ES (1) ES2090273T3 (es)
FR (1) FR2664386B1 (es)
GR (1) GR3020787T3 (es)
IE (1) IE74710B1 (es)
IL (1) IL98708A (es)
NZ (1) NZ238827A (es)
PT (1) PT98193B (es)
TW (1) TW262536B (es)
ZA (1) ZA915155B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6528994A (en) * 1993-04-02 1994-10-24 Pharmaceutical Discovery Corporation Renin/angiotensin i diagnostic assay
US5854388A (en) * 1993-06-24 1998-12-29 Washington State University Research Foundation Angiotensin IV peptides and receptor
US5693679A (en) * 1995-04-04 1997-12-02 Advanced Bioconcept, Inc. Fluorescent somatostatin
US6054557A (en) * 1995-04-04 2000-04-25 Advanced Bioconcept (1994) Ltd. Fluorescent peptides
US5824772A (en) * 1995-04-04 1998-10-20 Advanced Bioconcept, Inc. Fluorescent somatostatin
EP0820466A2 (en) * 1995-04-04 1998-01-28 Advanced Bioconcept Inc. Fluorescent peptides
US6815423B1 (en) 1995-07-20 2004-11-09 Perkinelmer Las, Inc. Fluorescent substance P
AU748903B2 (en) * 1997-06-24 2002-06-13 Proteus Molecular Design Limited Angiotensin derivatives
US6306616B1 (en) 1998-03-27 2001-10-23 Microgenics Corporation Adsorption type confirmatory assays
US6022696A (en) * 1998-04-02 2000-02-08 Washington State University Research Foundation Methods of identifying agonists or antagonists of angiotensin IV
KR100332577B1 (ko) * 1999-04-21 2002-04-17 김창덕 김 구이기
JP2004000110A (ja) * 2002-04-08 2004-01-08 Makoto Suzuki シート状海苔の焼加工装置
US7118747B2 (en) * 2003-09-30 2006-10-10 Pacific Northwest Biotechnology Inc. AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
US8236761B2 (en) * 2006-07-07 2012-08-07 Washington State University Research Foundation C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
EP2043675A2 (en) * 2006-07-07 2009-04-08 Washington State University Research Foundation C-met receptor regulation by angiotensin iv (at4) receptor ligands
KR101006369B1 (ko) * 2008-06-09 2011-01-10 김병복 김 공급장치
CN102749455B (zh) * 2012-06-26 2014-12-10 博奥赛斯（天津）生物科技有限公司 血管紧张素ⅱ化学发光免疫定量检测试剂盒及其制备方法
CN104614537A (zh) * 2015-02-10 2015-05-13 深圳市新产业生物医学工程股份有限公司 血管紧张素ⅱ检测试剂盒及其制备方法和应用
CN110031633A (zh) * 2019-03-30 2019-07-19 山西农业大学 不同毛色绵羊皮肤中血管紧张素ⅱ的表达试验方法
KR102199171B1 (ko) 2019-12-12 2021-01-06 강신탁 자동 김 공급 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4911909A (en) * 1987-01-02 1990-03-27 E. I. Du Pont De Nemours And Company Method of controlling hypertension using monoclonal antibodies to angiotensin-II

Also Published As

Publication number Publication date
FR2664386B1 (fr) 1992-10-23
DE69119656D1 (de) 1996-06-27
IE912313A1 (en) 1992-01-15
CA2046188A1 (en) 1992-01-06
AU7949391A (en) 1992-01-09
AU650028B2 (en) 1994-06-09
EP0466565B1 (fr) 1996-05-22
PT98193A (pt) 1993-08-31
ZA915155B (en) 1992-04-29
US5296354A (en) 1994-03-22
DE69119656T2 (de) 1996-12-05
GR3020787T3 (en) 1996-11-30
IE74710B1 (en) 1997-07-30
KR920003057A (ko) 1992-02-29
EP0466565A1 (fr) 1992-01-15
IL98708A0 (en) 1992-07-15
TW262536B (es) 1995-11-11
FR2664386A1 (fr) 1992-01-10
DK0466565T3 (da) 1996-09-30
NZ238827A (en) 1992-08-26
ATE138386T1 (de) 1996-06-15
PT98193B (pt) 1998-12-31
IL98708A (en) 1995-07-31
CA2046188C (en) 2000-09-19
JPH04232462A (ja) 1992-08-20

Similar Documents

Publication Publication Date Title
ES2090273T3 (es) Estuche para el dosificado especifico de la angiotensina ii.
JPS52117418A (en) Kit for quantitative analysis and method for using the same
EA199800946A1 (ru) Концентрированный препарат антител
NO930770L (no) Immunologisk fremgangsmaate for bestemmelse av et hemoglobinderivat
DK60586A (da) Inhibin isoleret fra ovariefollikelvaeske og fremgangsmaade til isolering og rensning af inhibin
DK261386A (da) Monoklonale antistoffer
DE69222956T2 (de) Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers
ATE178053T1 (de) N2s2-chelatoren des hydrazino-typs
ATE92634T1 (de) Verfahren zur bestimmung eines proteins nach dem prinzip des fluoreszenz-polarisations immunoassays.
DE69434384D1 (de) Metalkomplexbildner
CA2019671A1 (en) Oxidative denaturation of protein analytes
NO885836D0 (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opploesning.
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DE68911501T2 (de) Analgetische antacide Brausezusammensetzung mit reduziertem Natriumgehalt.
DE3684625D1 (de) Peptidverbindung und durch diese verbindung hergestelltes antiserum.
IT7823336A0 (it) Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa.
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
ATE218542T1 (de) Immuntestsystem zur bestimmung von vitamin d
RU94021664A (ru) Способ идентификации и количественного определения вредных побочных продуктов сульфирования методом ионной хроматографии
ZA832293B (en) Chromophoric peptides,a process for their preparation,agents containing them and their use for determining dd-carboxypeptidases
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
Rosenlöf et al. Radioimmunoassay of haemoglobin F in K 562 cells following induction with renin substrate and erythropoietin
ES2121409T3 (es) Metodo para determinar el contenido en lisina de semillas.
JPS5362823A (en) Enzyme-immuno-assay using peroxydase as labelling enzyme

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 466565

Country of ref document: ES

FG2A Definitive protection

Ref document number: 466565

Country of ref document: ES